Friday, September 11, 2020 8:01:23 PM
He says. “the FIRST unblinded look”. So we know they have not looked yet. So is it all 144 patients or the 102? I would agree with you it’s the 144 but why the change?
Also, if they had such good results with ARDS in SEPSIS back in early 2000s, why didn’t they chase that indication?
PS. I have a very large position and I like how this story is developing.
Also, if they had such good results with ARDS in SEPSIS back in early 2000s, why didn’t they chase that indication?
PS. I have a very large position and I like how this story is developing.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
